XDH and hyperuricemia: Here, we demonstrated the important role of liver XOR in causing high uric acid levels in vivo, and GalNAc-siRNA, which targets liver Xor, significantly protected the kidney from inflammation and fibrosis in hyperuricemia mouse models without hepatoxicity.